3rd Quarter - Report

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$340,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Education regarding the existing Department of Veterans Affairs Pharmaceutical Prime Vendor contract.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Meetings/education regarding the implementation of new medical device tax. Meetings/education regarding proposals to repeal LIFO.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Meetings/education regarding incentives for health information technology, health care reform implementation and other healthcare policy issues. Education regarding existing Vaccines for Children program. Proposed regulation of medical software.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

H.R. 905, to amend Part B of title XVIII of the Social Security Act S. 733, to amend part B of title XVIII of the Social Security Act Meetings/education regarding physician and pharmacy reimbursement issues

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
MATT BROW —
GEOFF WERTH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 733 (112th), H.R. 905 (112th)

Pharmacy PHA

Meetings/education regarding pharmacy issues

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.